IOVA

IOVA EBITDA Growth

29.26%TTM

Period ending:

IOVA TTM EBITDA YoY %%
IOVA TTM EBITDA YoY %1017.98%-8285.30%
2009-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IOVA ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 67 observations from Dec 31, 2009 to Jun 30, 2026.

Iovance Biotherapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
29.2563%
8.7872%
-4.6165%
6.1102%
12.4858%
18.212%
19.0604%
6.6725%
-2.7501%
-7.0269%
-10.5751%
-11.9568%
-12.8176%
-16.5411%
-16.877%
-21.0902%
-26.9649%
-28.4164%
-24.1724%
-16.2265%
-10.2513%
-10.1105%
-25.5324%
-46.6015%
-57.166%
-68.5185%
-61.5866%
-48.2421%
-50.472%
-43.3599%
-38.4846%
-45.3341%
-35.1519%
-47.5771%
-75.339%
-80.4024%
-131.989%
-133.0827%
-95.3534%
-92.2789%
-78.2864%
-92.0333%
-124.522%
-26.0073%
25.1051%
43.9988%
52.052%
-136.8214%
-2,653.4884%
-675.918%
-6,391.3692%
21.0334%
106.5096%
117.6639%
98.1692%
42.6647%
-28.9107%
-1,860.251%
-2,678.2413%
-5,350.7213%
-7,384.9808%
-1,650.1483%
-5,128.6011%
-1,106.908%
-519.0847%
-104.291%
74.1256%

Compare ebitda growth

All IOVA financial metrics · IOVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.